Latest News - First Citizens BancShares
Top Corporates Hub
First Citizens BancShares
Centene Corporation: The Margin Recovery Is Real, And The Market Is Still Catching Up
22.08.2026 04:12
Centene Corporation is executing a disciplined turnaround in government-sponsored healthcare. Find out why CNC stock is a buy.
Sandisk Surges: Top Industry-Leading Value Stocks
15.08.2026 06:00
Sandiskâs surge highlights renewed opportunities in value stocks. Discover three industry-leading companies with strong fundamentals and attractive valuations.
Carolina Complete Health Supports Young Leaders Through AMEXCAN Summer Camp
13.08.2026 15:40
Carolina Complete Health, a subsidiary of the Centene Corporation (NYSE: CNC), sponsored the AMEXCAN Summer Camp, helping provide 24 children from coastal North Carolina with a summer experience centered on learning, leadership and personal growth.
MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment
13.08.2026 13:30
Managed Health Services (MHS), a managed care entity that has been proudly serving the state of Indiana for 30 years and a Centene (NYSE: CNC) company, is proud to announce the recipients of the MHS Serves Workforce Support Program, a new statewide funding opportunity in partnership with Indiana Minority Health Coalition (IMHC) and Black Onyx Management, designed to strengthen workforce development programs that help Medicaid members prepare for employment, increase their income and build long-t
5 Undervalued Price-to-Book Stocks Worth Buying in August
13.08.2026 13:25
BioMarin, Invesco, Centene, HPE and Gibraltar Industries stand out as undervalued stocks with low price-to-book ratios.
Best Growth Stocks to Buy for August 13th
13.08.2026 07:31
SNDR, CNC, and TAL it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 13, 2026.
Argus Research Upgrades Centene to Buy, Announces $80 Price Target
11.08.2026 08:59
Argus Research analyst John Staszak upgrades Centene (NYSE:CNC) from Hold to Buy and announces $80 price target.
Oscar Health Stock Sinks Amid This Second-Half Risk
06.08.2026 15:31
Oscar Health dived Thursday morning, despite reporting better-than-expected earnings and raising its full-year outlook. Oscar said it sees more tailwinds than headwinds based on what it knows. Shifts in the ACA Marketplace due to the surge in premiums related to the end of enhanced government subsidies have transformed the market.
Why Centene (CNC) Is Up 8.4% After Raising 2026 Guidance and Redeeming 2027 Notes - And What's Next
06.08.2026 04:31
Centene Corporation recently reported past second-quarter 2026 results showing revenue of US$53,579 million and net income of US$1,091 million, while also announcing a partial US$500 million redemption of its 4.25% Notes due 2027 and leadership changes on its board. The company’s raised full-year 2026 revenue and earnings guidance, alongside institutional investor focus on Medicaid margin recovery, has sharpened attention on its managed care profitability trajectory. Now we’ll examine how...
Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says
29.07.2026 15:43
Centene (CNC) delivered a stronger-than-expected Q2, but investor attention shifted to management's
Centene Stock Q2 Earnings Call Highlights Margin Recovery
29.07.2026 14:00
CNC highlights margin recovery, stronger Marketplace results and raised 2026 EPS outlook as cost discipline supports profitability gains.
Centene (CNC) Returns To Profit As Paul J. Diaz Joins The Board
29.07.2026 12:08
Centene (NYSE:CNC) reported a swing to profitability in Q2 2026 after a prior period of losses. The company highlighted strong performance in its Affordable Care Act marketplace business during the quarter. Centene raised its financial guidance for the year alongside the Q2 results. Kenneth A. Burdick plans to retire from the board, with experienced healthcare executive Paul J. Diaz joining as a new director. Centene enters this news cycle with its stock at $63.91 and a move up of 53.0%...
Barclays Maintains Overweight on Centene, Raises Price Target to $80
29.07.2026 08:09
Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $75 to $80.
Baird Maintains Neutral on Centene, Raises Price Target to $66
29.07.2026 07:22
Baird analyst Michael Ha maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $46 to $66.
Centene's Margin Recovery Keeps The Upside Alive
29.07.2026 04:29
Centene (CNC) Buy case: Q2 EPS beat, cash flow surge, and margin-focused Medicaid/Medicare strategy. Read here for more details.
Why Centene (CNC) Shares Are Sliding Today
29.07.2026 03:17
Shares of health coverage company Centene (NYSE:CNC) fell 5.1% in the morning session after a significant decline in membership appeared to overshadow an otherwise strong second-quarter earnings report where the company beat expectations and raised its full-year profit forecast. Centene's adjusted earnings per share of $2.51 and revenue of $53.58 billion both significantly surpassed analyst estimates. The health insurer also increased its full-year adjusted profit guidance to $4.80 per share at
Centene (CNC) Q2 2026 Earnings Call Transcript
29.07.2026 00:57
Sarah London discusses margin expansion and dual-eligible Medicare focus.
Barclays Maintains Equal-Weight on First Citizens BancShares, Raises Price Target to $2376
27.07.2026 07:29
Barclays analyst Jason Goldberg maintains First Citizens BancShares (NASDAQ:FCNCA) with a Equal-Weight and raises the price target from $2346 to $2376.